Oncofertility and Young Breast Cancer Patients: Why This Conversation Needs to Happen at Diagnosis — Not After

If you are a young woman who has just been diagnosed with breast cancer, there is a conversation that needs to happen right now — today, this week, before your treatment plan is finalized. Not in a few weeks. Not after your first chemo infusion. Now.

I’m Cynthia Jordan, founder of Learn Look Locate and a breast cancer survivor. I went through IVF three times in my early thirties, and I was diagnosed with breast cancer in my fifties. Those two experiences — as separate as they were for me — gave me a deep understanding of what each one asks of a woman. And I know that for the roughly 10 percent of women diagnosed with breast cancer under the age of 45, they don’t get the luxury of separating them.

That is why we built the Fertility Preservation resource on Learn Look Locate — and why I brought in two of my own medical advisors, Dr. Deborah Ikhena-Abel and Laly Havern, to make sure it reflects both the clinical and the practical reality of what young women actually face. This blog is about the field of oncofertility — what it is, why it matters, and why the timing of this conversation is everything.

What Is Oncofertility?

Oncofertility is the medical field that sits at the intersection of cancer care and reproductive medicine. The premise is straightforward: treating cancer and protecting future fertility should be part of the same conversation — not two separate conversations that happen weeks apart.

In practice, that means a young woman who is diagnosed with breast cancer receives a clear, early explanation of how her specific treatment plan may affect her fertility. It means she knows what preservation options exist and how to access them. It means her oncologist and her reproductive endocrinologist are talking to each other. And it means the window — which can be as short as 10 to 14 days before chemotherapy begins — does not close before she even knows it was open.

That last part is where the system most often fails young patients. Not from lack of care. From lack of coordination and timing.

Why Young Women Are a Distinct Group in This Conversation

Approximately 10 percent of all new breast cancer diagnoses occur in women under 45. These are women who may be years away from completing their families — or who haven’t started yet. For them, a breast cancer diagnosis doesn’t just threaten their health. It threatens their timeline, their options, and a future they had every right to expect.

Chemotherapy affects the ovaries. Certain drugs are particularly hard on ovarian reserve, and the younger a woman is, the more she stands to lose if preservation steps aren’t taken before treatment begins. Hormone therapy — often prescribed for 5 to 10 years for hormone receptor-positive breast cancers — further delays when pregnancy is safely possible. For a woman in her late twenties or early thirties, that timeline matters enormously.

And yet this conversation still does not happen consistently at diagnosis. That is not acceptable. And it is exactly what oncofertility — and resources like the one we built at Learn Look Locate — are working to change.

The Questions Every Young Patient Deserves Answers To at Diagnosis

These are not complicated questions. They are the right questions — and they should be asked and answered before treatment begins:

• How will my specific treatment plan affect my fertility, and what is my personal risk of treatment-related menopause?
• Is there time for me to see a reproductive endocrinologist before treatment begins?
• Which fertility preservation options are realistic for my diagnosis and timeline?
• What will this cost, and what programs exist specifically for cancer patients?
• Who on my care team will coordinate between my oncologist and my fertility specialist?
• How do I get my medications quickly enough if I decide to move forward?

If no one on your care team has raised these questions, raise them yourself. You are your own best advocate — and you now know enough to ask.

Dr. Deborah Ikhena-Abel: The Reproductive Endocrinologist Who Makes This Possible

Dr. Deborah E. Ikhena-Abel, MD, MSCI — Learn Look Locate Medical Advisor

Dr. Ikhena-Abel is a double board-certified reproductive endocrinologist and infertility specialist practicing at Aspire Fertility in Austin, Texas, and one of my medical advisors at Learn Look Locate. She works directly with young cancer patients — helping them understand their fertility risks, evaluate their preservation options, and coordinate with their oncology teams so that the window does not close before they can act on it.

She joined Learn Look Locate because she believes that every young woman facing breast cancer deserves this conversation at diagnosis — not as a rushed afterthought, but as a central part of her care.

“I’m passionate about empowering women with breast cancer to understand their fertility preservation options. As a fertility doctor, I believe every woman deserves the chance to protect her future family while navigating treatment. This platform blends trusted medical insight with real stories, creating a powerful space for informed, hopeful decision-making.”
— Dr. Deborah E. Ikhena-Abel
Meet Dr. Ikhena-Abel at Learn Look Locate

Laly Havern: The Pharmacist Who Closes the Access Gap

Lalymar ‘Laly’ Havern, PharmD, MS, BCACP — Learn Look Locate Medical Advisor

Even when a young patient is connected to a reproductive endocrinologist in time, there is still a logistical obstacle that can derail everything: getting fertility medications fast enough to begin the stimulation cycle before treatment starts. These are specialty drugs — unavailable at standard retail pharmacies, requiring prior authorization, cold-chain shipping, and tight coordination between the fertility clinic and the pharmacy.

Laly Havern is a board-certified oncology pharmacist and one of my medical advisors at Learn Look Locate. She is the person who makes sure that ‘what is medically possible’ and ‘what patients can actually access’ are the same conversation — not two separate ones.

“As pharmacists, we stand at a critical point in care where we can bridge gaps that might otherwise be missed — ensuring patients are truly supported, informed, and empowered during one of the most vulnerable moments of their lives.”
— Laly Havern, PharmD
Meet Laly Havern at Learn Look Locate

What Happens When This Conversation Doesn’t Happen in Time

The window for egg or embryo freezing closes once chemotherapy begins. After that, the options narrow significantly. Some women may still be candidates for ovarian tissue freezing in limited circumstances, but the most established and effective methods require that 10 to 14-day stimulation window before treatment starts.

Women who are not told about fertility preservation at diagnosis — or who are told too late — may face a future where the options they would have chosen are simply no longer available. That is not a medical inevitability. It is a communication failure. And it is preventable.

Frequently Asked Questions From Young Breast Cancer Patients

Q1. I just got diagnosed. Is it really the right time to be thinking about fertility?
A: Yes — and unfortunately the timing is non-negotiable. The window for the most effective fertility preservation methods opens now and closes quickly. You don’t have to have everything figured out. You just have to start the conversation while the option still exists.

Q2. My oncologist hasn’t mentioned fertility preservation. Should I bring it up?
A: Absolutely. Not every oncologist raises this proactively, and that is not a reflection of your care — it is a gap in the system. Tell your oncologist you want to discuss fertility preservation before treatment begins and ask for a referral to a reproductive endocrinologist with oncofertility experience.

Q3. What if I’m not in a relationship or not sure I want children?
A: You don’t need a partner, and you don’t need certainty. Egg freezing preserves your options without requiring any decisions about how or whether you’ll use them. Future you deserves to have the choice.

Q4. How do I find a reproductive endocrinologist who works with cancer patients?
A: Ask your oncologist for a referral, or search for fertility clinics that specifically mention oncofertility services. Many major fertility clinic networks have dedicated oncofertility programs and are experienced in moving quickly when treatment timelines are tight.

Q5. Will insurance cover any of this?
A: Coverage varies widely by plan and state, but it is improving. Several states now mandate coverage for fertility preservation when infertility risk is a result of cancer treatment. Even if your plan denies coverage initially, an appeal supported by a letter of medical necessity is often successful. Assistance programs — including Ferring’s Heartbeat Program, LIVESTRONG Heartbeat, Chick Mission, and ReUnite Onco — also exist specifically to help cancer patients with these costs.

The Learn Look Locate Fertility Preservation guide covers all of this — options, timing, medications, costs, emotional support, and the expert guidance of Dr. Ikhena-Abel and Laly Havern — in one place, built specifically for young women navigating this moment.
Read the Full Oncofertility Guide at Learn Look Locate